TheraCell, Inc. acquired by Isto Biologics
We are pleased to announce that we signed an agreement for TheraCell, Inc. to be acquired by Isto Biologics.
We believe that this transaction creates significant opportunities to continue offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. We are pleased that Isto, a leader in allogeneic spine solutions, has recognized the value and importance of what we have developed and are excited about how their patient-centric, outcomes-focused commercial and clinical teams will rapidly accelerate the surgical adoption of the products and technology.
